I am currently working as a Postdoctoral Research Associate investigating thallium distribution inside individual cells to help design a therapeutic targeted on a subcellular level. During my PhD studies I explored the potential of thallium-201 radiotoxicity for cancer therapy and developed approaches for incorporating thallium-201 into targeted radiopharmaceuticals. My academic background is deeply rooted in pharmaceutical care, and I earned my MPharm degree from the Medical University of Warsaw. In the final year of my master's studies, I participated in research involving the synthesis of novel vitamin B12 - protoporphyrin IX hybrid molecules with potential applications in heart disease treatment, based at the Institute of Organic Chemistry, Polish Academy of Sciences.

After graduating, I acquired practical experience in community and clinical pharmacy, specialising as a clinical oncology pharmacist with a focus on multidisciplinary cancer patient care. My research interests lie in the development of novel drug therapies and the utilisation of cutting-edge techniques to pioneer innovative solutions in the field of cancer treatment.